Consistently, it has been reported that the increased expression of CCL17 and CCL22 correlates with the infiltration of CCR4-expressing Treg cells and poor clinical outcomes in gastric cancer, breast cancer, and oral tongue squamous cell carcinoma (Table 1) [62,162,172]. Here, CCL17 is linked to breast cancer.